255 related articles for article (PubMed ID: 17695436)
41. Chemotherapy for recurrent cervical cancer.
Cadron I; Van Gorp T; Amant F; Leunen K; Neven P; Vergote I
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S113-8. PubMed ID: 17804044
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model.
Mountzios G; Bamias A; Voulgaris Z; Rodolakis A; Vlahos G; Gourgoulis G; Papaiakovou EE; Giannopoulos A
Gynecol Oncol; 2008 Jan; 108(1):130-5. PubMed ID: 17988722
[TBL] [Abstract][Full Text] [Related]
43. Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.
Lim JY; Jeung HC; Mun HS; Lee DK; Paik YH; Lee SJ; Yoon DS; Cho JY
Anticancer Drugs; 2008 Jul; 19(6):631-5. PubMed ID: 18525323
[TBL] [Abstract][Full Text] [Related]
44. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
Medina PJ; Goodin S
Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
[TBL] [Abstract][Full Text] [Related]
45. [Chemotherapy of esophageal carcinoma].
Herrmann R
Schweiz Med Wochenschr; 1993 May; 123(21):1103-5. PubMed ID: 8511542
[TBL] [Abstract][Full Text] [Related]
46. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
Hsiao SM; Chen CA; Hsu C; Lin HH; Hsieh CY; Wei LH
Anticancer Res; 2008; 28(3B):1887-91. PubMed ID: 18630476
[TBL] [Abstract][Full Text] [Related]
47. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
[TBL] [Abstract][Full Text] [Related]
48. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
49. Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
Meier W; du Bois A; Reuss A; Kuhn W; Olbricht S; Gropp M; Richter B; Lück HJ; Kimmig R; Pfisterer J
Gynecol Oncol; 2009 Aug; 114(2):199-205. PubMed ID: 19446314
[TBL] [Abstract][Full Text] [Related]
50. Combined infusional chemotherapy and radiation for esophageal carcinoma: a review.
Chauveinc L; Giralt EG
J Infus Chemother; 1995; 5(4):215-7. PubMed ID: 8934732
[No Abstract] [Full Text] [Related]
51. A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.
Zhang X; Shen L; Li J; Li Y; Li J; Jin M
Am J Clin Oncol; 2008 Feb; 31(1):29-33. PubMed ID: 18376224
[TBL] [Abstract][Full Text] [Related]
52. Evolving chemotherapy for advanced gastric cancer.
Ajani JA
Oncologist; 2005; 10 Suppl 3():49-58. PubMed ID: 16368871
[TBL] [Abstract][Full Text] [Related]
53. Management of metastatic cervical cancer: review of the literature.
Long HJ
J Clin Oncol; 2007 Jul; 25(20):2966-74. PubMed ID: 17617528
[TBL] [Abstract][Full Text] [Related]
54. Targeted therapies for esophageal cancer.
Tew WP; Kelsen DP; Ilson DH
Oncologist; 2005 Sep; 10(8):590-601. PubMed ID: 16177283
[TBL] [Abstract][Full Text] [Related]
55. Role of systemic chemotherapy in metastatic cervical cancer.
Hogg R; Friedlander M
Expert Rev Anticancer Ther; 2003 Apr; 3(2):234-40. PubMed ID: 12722882
[TBL] [Abstract][Full Text] [Related]
56. The role of chemotherapy in the treatment of esophageal cancer.
Kelsen DP
Chest Surg Clin N Am; 1994 Feb; 4(1):173-84. PubMed ID: 8055280
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapy of breast cancer treatment of metastatic, recurrent or inoperable breast cancer.
Falkson G; Falkson HC
S Afr J Surg; 1975 Sep; 13(3):121-7. PubMed ID: 54941
[No Abstract] [Full Text] [Related]
58. Treatment of advanced esophageal cancer.
Kelsen D
Cancer; 1982 Dec; 50(11 Suppl):2576-81. PubMed ID: 6182976
[TBL] [Abstract][Full Text] [Related]
59. [Cholangiocellular and gallbladder carcinoma].
Kubicka S
Z Gastroenterol; 2004 May; 42(5):397-402. PubMed ID: 15136940
[TBL] [Abstract][Full Text] [Related]
60. [Principles of drug therapy of malignant tumors: the role of malignant progression in the choice of effective drugs].
Jeney A; Rosta A
Orv Hetil; 1999 May; 140(22):1245-9. PubMed ID: 10377736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
